Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results

The optimal treatment strategy and outcome of non-gastric marginal zone lymphoma (MZL) remains undefined. The role of rituximab and fludarabine in MZL has not been critically appraised and compared with conventional chemotherapy. We retrospectively analyzed 81 consecutive patients with non-gastric M...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Harinder, Chim, Chor-Sang, Au, Wing-Yan, Loong, Florence, Tse, Eric, Leung, Anskar Y. H., Kwong, Yok-Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210355/
https://www.ncbi.nlm.nih.gov/pubmed/21476016
http://dx.doi.org/10.1007/s00277-011-1226-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210355/
https://www.ncbi.nlm.nih.gov/pubmed/21476016
http://dx.doi.org/10.1007/s00277-011-1226-z

Ejemplares similares